A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

Phase 4 COMPARE trial data show Nuvaxovid was associated with lower reactogenicity and fewer daily activity disruptions than mNEXSPIKE.

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), a biotechnology company focused on gene therapies for age-related ...

A Honolulu research team is drawing attention far beyond the islands after reporting that an experimental mRNA therapy cut ...

The AIRFoundry facility — funded by a six-year, $18 million National Science Foundation grant — brings together researchers ...

Scientific discoveries have been making leaps and bounds at every increasing rates but unfortunately mankind hasn’t been as ...

As drug candidates advance through clinical development, their value increases significantly due to rising probabilities of success and proximity to commercialization. The rise of fair-value ...

Almost half of the participants in an early trial of an mRNA-based vaccine to fight pancreatic cancer were alive and well up ...

Wobble Genomics will present new data at the AACR Annual Meeting 2026, highlighting its approach to sequencing full-length mRNA from blood to support antibody-drug conjugate (ADC) therapy selection in ...

Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...

The National Science Foundation’s (NSF) future is in limbo as President Trump pushes for more budget cuts and his nominee to ...